Literature DB >> 20669030

Biliary atresia: the Croatian experience 1992-2006.

Ruža Grizelj1, Jurica Vuković, Milivoj Novak, Stipe Batinica.   

Abstract

The objective of this study was to determine the outcomes of Croatian children with biliary atresia. Health records of infants born in Croatia between January 1, 1992 and December 31, 2006 who were diagnosed with biliary atresia and treated at a single university center were reviewed. Survival rates were calculated with the Kaplan-Meier method. Twenty-nine patients with biliary atresia were identified. Incidence was one in 23,600 live births (95% confidence interval 1/17,400-1/27,200). The median age at Kasai operation was 66 days (range 22-192). Median follow-up was 2.65 years (range 0.2-14.3). Overall survival rates for the patients who underwent Kasai portoenterostomy, including those six (20%) who subsequently underwent liver transplantation, were 75.6%. Five and 10-year native liver survival rates were 51.7% and 38.8%, respectively (median survival time was 7.88 years). Survival rate curves in two groups of patients according to the biliary atresia phenotype (fetal or perinatal form) were divergent. Survival was 87.7% in perinatal form and 43.8% in fetal form (Breslow chi-square 8.082, p < 0.01). Overall survival rates of patients with biliary atresia in Croatia compared unfavorably with current international standards; this could be improved with earlier referral for liver transplantation. Results of Kasai operation (native liver survival rates) compared favorably with results reported elsewhere.

Entities:  

Mesh:

Year:  2010        PMID: 20669030     DOI: 10.1007/s00431-010-1266-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

Review 1.  Pathogenesis and outcome of biliary atresia: current concepts.

Authors:  Ronald J Sokol; Cara Mack; Michael R Narkewicz; Frederick M Karrer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-07       Impact factor: 2.839

2.  Epidemiology of biliary atresia: a population-based study.

Authors:  P W Yoon; J S Bresee; R S Olney; L M James; M J Khoury
Journal:  Pediatrics       Date:  1997-03       Impact factor: 7.124

Review 3.  Unraveling the pathogenesis and etiology of biliary atresia.

Authors:  Cara L Mack; Ronald J Sokol
Journal:  Pediatr Res       Date:  2005-04-06       Impact factor: 3.756

4.  A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000.

Authors:  Benjamin L Shneider; Morton B Brown; Barbara Haber; Peter F Whitington; Kathleen Schwarz; Robert Squires; Jorge Bezerra; Ross Shepherd; Philip Rosenthal; Jay H Hoofnagle; Ronald J Sokol
Journal:  J Pediatr       Date:  2006-04       Impact factor: 4.406

Review 5.  Biliary atresia.

Authors:  M Nio; R Ohi
Journal:  Semin Pediatr Surg       Date:  2000-11       Impact factor: 2.754

6.  Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry.

Authors:  Masaki Nio; Ryoji Ohi; Takeshi Miyano; Morihiro Saeki; Kazuo Shiraki; Koichi Tanaka
Journal:  J Pediatr Surg       Date:  2003-07       Impact factor: 2.545

7.  Cholestatic jaundice in infancy. The importance of familial and genetic factors in aetiology and prognosis.

Authors:  N T Henriksen; P A Drabløs; O Aagenaes
Journal:  Arch Dis Child       Date:  1981-08       Impact factor: 3.791

8.  Impact of age at Kasai operation on its results in late childhood and adolescence: a rational basis for biliary atresia screening.

Authors:  Marie-Odile Serinet; Barbara E Wildhaber; Pierre Broué; Alain Lachaux; Jacques Sarles; Emmanuel Jacquemin; Frédéric Gauthier; Christophe Chardot
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

Review 9.  Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.

Authors:  Ronald J Sokol; Ross W Shepherd; Riccardo Superina; Jorge A Bezerra; Patricia Robuck; Jay H Hoofnagle
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

10.  Time-space distribution of extrahepatic biliary atresia in The Netherlands and West Germany.

Authors:  R H Houwen; I I Kerremans; H A van Steensel-Moll; L K van Romunde; C M Bijleveld; P Schweizer
Journal:  Z Kinderchir       Date:  1988-04
View more
  5 in total

1.  Revisiting long-term prognostic factors of biliary atresia: A 20-year experience with 81 patients from a single center.

Authors:  Damla Hanalioğlu; Hasan Özen; Asuman Karhan; Ersin Gümüş; Hülya Demir; İnci N Saltık-Temizel; Saniye Ekinci; İbrahim Karnak; Arbay O Çiftçi; Feridun C Tanyel; Aysel Yüce
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

2.  Ductal plate malformation in patients with biliary atresia.

Authors:  Jurica Vuković; Ruža Grizelj; Katarina Bojanić; Marijana Corić; Tomislav Luetić; Stipe Batinica; Mirjana Kujundžić-Tiljak; Darrell R Schroeder; Juraj Sprung
Journal:  Eur J Pediatr       Date:  2012-09-15       Impact factor: 3.183

3.  Epidemiology of Biliary Atresia in Korea.

Authors:  Kyung Jae Lee; Ju Whi Kim; Jin Soo Moon; Jae Sung Ko
Journal:  J Korean Med Sci       Date:  2017-04       Impact factor: 2.153

4.  Congenital aflatoxicosis, mal-detoxification genomics & ontogeny trigger immune-mediated Kotb disease biliary atresia variant: SANRA compliant review.

Authors:  Magd A Kotb; Ahmed Kotb; Sahar Talaat; Sherif M Shehata; Nabil El Dessouki; Ahmed A ElHaddad; Gamal El Tagy; Haytham Esmat; Sameh Shehata; Mohamed Hashim; Hanan A Kotb; Hanan Zekry; Hesham M Abd Elkader; Sherif Kaddah; Hend E Abd El Baky; Nabil Lotfi
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

5.  Associations of mitochondrial haplogroups b4 and e with biliary atresia and differential susceptibility to hydrophobic bile Acid.

Authors:  Mao-Meng Tiao; Chia-Wei Liou; Li-Tung Huang; Pei-Wen Wang; Tsu-Kung Lin; Jin-Bor Chen; Yao-Min Chou; Ying-Hsien Huang; Hung-Yu Lin; Chao-Long Chen; Jiin-Haur Chuang
Journal:  PLoS Genet       Date:  2013-08-15       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.